You are here

Article Text

Article menu
Download PDFPDF
CASE REPORT
Intrapleural cisplatin for management of malignant pleural effusion in a patient with plasma cell leucaemia
  1. Abhishek Agarwal1,
  2. Jagpal Klair2,
  3. Setu Patolia3,
  4. Nikhil K Meena4
  1. 1Cooper University Hospital, Camden, New Jersey, USA
  2. 2Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
  3. 3University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
  4. 4Department of Pulmonary and Critical Care Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
  1. Correspondence to Dr Abhishek Agarwal, agarwal-abhishek{at}cooperhealth.edu

Summary

Plasma cell leucaemia (PCL) is a rare aggressive form of multiple myeloma. It occasionally involves the pleura, causing malignant pleural effusion (MPE). MPE presents a management dilemma for physicians, given the different treatment options available with varying efficacy and side effects. We report a case of a 64-year-old man with MPE due to PCL, successfully managed with intrapleural cisplatin and a tunnelled pleural catheter. We believe this to be the first report of management of PCL-associated MPE with intrapleural cisplatin.

https://doi.org/10.1136/bcr-2015-210044

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text